Sumitomo Mitsui Ds Asset Management Company, LTD Moderna, Inc. Transaction History
Sumitomo Mitsui Ds Asset Management Company, LTD
- $10.9 Billion
- Q2 2025
A detailed history of Sumitomo Mitsui Ds Asset Management Company, LTD transactions in Moderna, Inc. stock. As of the latest transaction made, Sumitomo Mitsui Ds Asset Management Company, LTD holds 8,931 shares of MRNA stock, worth $254,444. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,931
Previous 34,963
74.46%
Holding current value
$254,444
Previous $991,000
75.18%
% of portfolio
0.0%
Previous 0.01%
Shares
21 transactions
Others Institutions Holding MRNA
# of Institutions
861Shares Held
267MCall Options Held
28.5MPut Options Held
34.8M-
Vanguard Group Inc Valley Forge, PA41.7MShares$1.19 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$728 Million0.07% of portfolio
-
Baillie Gifford & CO22.1MShares$629 Million0.48% of portfolio
-
State Street Corp Boston, MA17.3MShares$492 Million0.02% of portfolio
-
Geode Capital Management, LLC Boston, MA8.88MShares$253 Million0.02% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $11.1B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...